Conn. pharmaceutical company to lay off more than 200


The New Haven Register reports that a spokeswoman for Alexion Pharmaceuticals said Monday that the 210 layoffs represent about 7 percent of Alexion's 3,000-person workforce. The biopharmaceutical company, which makes drugs to treat rare diseases, says the move aims to help position the company for "sustainable, long-term growth."



from Biotech News